| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5872100 | Clinical Nutrition | 2012 | 6 Pages |
Abstract
Our data showed that an increased erythrocytes long-chain n-3 and n-6 fatty acids was associated with a lower prevalence of steatosis in patients with type 2 diabetes. These results suggest that n-3 and n-6 fatty acids supplementation could be a promising treatment for NAFLD in patients with type 2 diabetes.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
J.M. Petit, B. Guiu, L. Duvillard, V. Jooste, M.C. Brindisi, A. Athias, B. Bouillet, M. Habchi, V. Cottet, P. Gambert, P. Hillon, J.P. Cercueil, B. Verges,